F5 - coagulation factor V Gene

Also Known as Ac2-120

Species: Rattus norvegicus

Gene Type: protein coding
Gene ID: 304929

Summary

Predicted to enable oxidoreductase activity. Involved in blood coagulation and response to vitamin K. Located in Golgi apparatus; endoplasmic reticulum; and extracellular space. Used to study membranoproliferative glomerulonephritis. Biomarker of hepatitis and portal hypertension. Human ortholog(s) of this gene implicated in several diseases, including artery disease (multiple); end stage renal disease; factor V deficiency; liver disease (multiple); and non-arteritic anterior ischemic optic neuropathy. Orthologous to human F5 (coagulation factor V). [provided by Alliance of Genome Resources, Apr 2022]

F5 Products (1)

mRNA Protein Name
NM_001047878.1 NP_001041343.1 coagulation factor V

Gene Ontology

  • Biological Process
  • Cellular Component
Biological Process GO Annotation Evidence References Source
involved in response to vitamin K IEP
IEP: Inferred from expression pattern
658784 RGD
Cellular Component GO Annotation Evidence References Source
located in extracellular region IDA
IDA: Inferred from direct assay
15172885 RGD
located in extracellular space IDA
IDA: Inferred from direct assay
3956160 RGD
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

coagulation factor V

  • coagulation factor V (proaccelerin, labile factor)

Related Agents

  • Clinical Phase
  • Pre-clinical Phase

Clinical Phase

Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Phase
HY-P0039 BIM-26226 Antagonist 98.73% Phase 1

Pre-clinical Phase

Bioactive Molecules (60)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-112698 CA-5f 99.14% Unkown
HY-108277 Ginsenoside F5 Inducer 99.90% Unkown
HY-W093272 Thalidomide-5,6-F Inducer 99.84% Unkown
HY-132226 Desamino lenalidomide-5-F 97.72% Unkown
HY-124421 5F-203 Inducer 98.04% Unkown
HY-W010811 Fmoc-Phe(F5)-OH 99.08% Unkown
HY-P5367 5-FAM-PMDM6 97.06% Unkown
HY-R01575 hsa-miR-518f-5p mimic 92.38% Unkown
HY-RI01575 hsa-miR-518f-5p inhibitor 99.28% Unkown
HY-118847 Antifungal agent 86 Inhibitor / Unkown
HY-147698 ZLHQ-5f / Unkown
HY-185609 m7G(2'F)(5')ppp(5')(2'OMeA)pG triammonium / Unkown
HY-D1410 DMTr-4'-F-5-Me-U-CED phosphoramidite / Unkown
HY-D1779 Fura-5F pentapotassium / Unkown
HY-N8311 Goshonoside F5 Inhibitor / Unkown
HY-P11865 Ac-ATS010-KE Inhibitor / Unkown
HY-P2579 Dafphedyn Agonist / Unkown
HY-P4020 2F5 epitope / Unkown
HY-P4025 ELDKWA / Unkown
HY-R01575A hsa-miR-518f-5p agomir / Unkown
HY-R01604 hsa-miR-520f-5p mimic / Unkown
HY-R01604A hsa-miR-520f-5p agomir / Unkown
HY-R01684 hsa-miR-548f-5p mimic / Unkown
HY-R01684A hsa-miR-548f-5p agomir / Unkown
HY-R03052 mmu-miR-344f-5p mimic / Unkown
HY-R03052A mmu-miR-344f-5p agomir / Unkown
HY-R03177 mmu-miR-466f-5p mimic / Unkown
HY-R03177A mmu-miR-466f-5p agomir / Unkown
HY-R03468 mmu-miR-669f-5p mimic / Unkown
HY-R03468A mmu-miR-669f-5p agomir / Unkown
HY-RI01575A hsa-miR-518f-5p antagomir / Unkown
HY-RI01604 hsa-miR-520f-5p inhibitor / Unkown
HY-RI01604A hsa-miR-520f-5p antagomir / Unkown
HY-RI01684 hsa-miR-548f-5p inhibitor / Unkown
HY-RI01684A hsa-miR-548f-5p antagomir / Unkown
HY-RI03052 mmu-miR-344f-5p inhibitor / Unkown
HY-RI03052A mmu-miR-344f-5p antagomir / Unkown
HY-RI03177 mmu-miR-466f-5p inhibitor / Unkown
HY-RI03177A mmu-miR-466f-5p antagomir / Unkown
HY-RI03468 mmu-miR-669f-5p inhibitor / Unkown
HY-RI03468A mmu-miR-669f-5p antagomir / Unkown
HY-RS04114 E2F5 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS04644 F5 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS09816 OR4F5 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W124385 5,5-Difluoro-1,3-dimethyl-5H-5lambda4,6lambda4-dipyrrolo[1,2-c:2',1'-f][1,3 / Unkown
HY-W877994 Thalidomide-6-F-5-pip-CHO 95.0% Unkown
HY-180495 5-MeO-NBpBrT / Unkown
HY-201022 5'-O-DMT-2'-F-5-MeO-U-3'-CE Phosphoramidite / Unkown
HY-201028 5'-C2-O-DMT-2'-F-5-MeO-U-3'-CE Phosphoramidite / Unkown
HY-R04617 mmu-let-7f-5p mimic / Unkown
HY-RS16905 F5 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS20723 E2f5 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS23347 F5 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS27235 E2f5 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W453715 Thalidomide-4-F,5-Br 99.37% Unkown
HY-W586320 Thalidomide-5-Br,6-F / Unkown
HY-W998241 Thalidomide-6-F-5-azetidine-COOH / Unkown
HY-W998242 Thalidomide-6-F-5-Pip-COOH / Unkown
HY-W998335 (S)-Deoxy-thalidomide-6-F-5-piperazine benzenesulfonate / Unkown
HY-W998346 Thalidomide-5-NH2-6-F / Unkown
Bioactive MoleculesInhibitory Antibodies (2)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P990255 Anti-Mouse CXCL9/MIG Antibody (MIG-2F5.5) Inhibitor 95.00% Unkown
HY-P990221 Anti-Mouse IL-17F Antibody (MM17F8F5.1A9) Inhibitor ≥95.0% Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens F5 NCBI NCBI:2153
Canis familiaris F5 NCBI NCBI:100685858
Felis catus F5 NCBI NCBI:101085264
Macaca fascicularis F5 NCBI NCBI:102141482
Canis lupus familiaris F5 NCBI
Mus musculus F5 NCBI NCBI:14067
Leporidae F5 NCBI
Macaca mulatta F5 NCBI NCBI:704695